Long Term Care Journal
Friday, September 7, 2018
FDA approves new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence - FDA Press Releases
FDA approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid dependence.
from Food and Drug Administration--Press Releases https://ift.tt/2oQgz4w
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment